Home / Market News / $MEDP
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

Truist Securities Adjusts Price Target on Medpace Holdings

Oct 23, 2026, 11:34 AM UTC · Primary ticker $MEDP

Truist Securities has increased its price target for Medpace Holdings from $609 to $633, while maintaining a 'Hold' rating. This indicates a slightly more optimistic valuation by the analyst, but not a change in investment recommendation, suggesting a moderate positive sentiment for the stock.

Truist Securities has adjusted its price target for Medpace Holdings (MEDP) upwards from $609 to $633. This change reflects an updated analyst assessment of the company's valuation and market position, suggesting a slightly improved outlook. However, the 'Hold' rating remains unchanged, indicating that while the valuation has improved, Truist does not see a compelling reason to upgrade their investment recommendation. For traders, this is a moderately positive signal in the short term, as it could provide some upward momentum for MEDP's stock price. The long-term implications are less clear without a change in the rating, but it suggests continued analyst confidence in the company's underlying business. A key opportunity for traders might be a short-term price bump, but the unchanged 'Hold' rating limits significant upside expectations.

$MEDP positive Price target increase
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.